TheStreet.com Ratings: Week's Best, Worst Health/Biotech Funds
A Democratic victory puts the sector in play.
Shiny New Quarter: Funds Post Across-the-Board Recovery
Nearly all fund sectors are up in the second quarter, after all were negative in the first period.
The Daily Interview: GenomicsFund.com's Steve Newby
It suffered huge losses on Monday, but its manager is still optimistic about his niche.
Onyx Discovers That Something Old Can Be New Again
Onyx's stock moved Tuesday on news from May. Unexpected? Yes. Uncommon? No.
BP Among Leaders of Fair Value Increases by Morningstar
In the energy sector, 25% of the companies covered by Morningstar garnered fair-value increases of more than 10%.
Nvidia Stock: Investors Are Buying the Dip. Where From Here?
Nvidia stock is being bought on the dip. Here's how traders should approach it now.
Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal
"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.